SMTL ID : 9cd5.1 (1 other biounit)

FGFR1 Kinase Domain Soak with Inhibitor TYRA-300

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.94 Å

Oligo State

monomer

Ligands

2 x EDO: 1,2-ETHANEDIOL

EDO.1: 6 residues within 4Å: Chain A: E.74, M.78, I.88, D.184, F.185, G.186 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:F.185, A:G.186 EDO.2: 5 residues within 4Å: Chain A: K.109, E.114, Y.115, R.119 Ligands: 01.3 3 PLIP interactions: 3 interactions with chain A Hydrogen bonds: A:E.114, A:R.119, A:R.119

1 x 01: (3P)-5-[(1R)-1-(3,5-dichloropyridin-4-yl)ethoxy]-3-{6-[6-(methanesulfonyl)-2,6-diazaspiro[3.3]heptan-2-yl]pyridin-3-yl}-1H-indazole

01.3: 16 residues within 4Å: Chain A: L.27, G.28, V.35, A.55, V.104, E.105, Y.106, A.107, S.108, G.110, N.111, E.114, R.170, L.173, D.184 Ligands: EDO.2 9 PLIP interactions: 9 interactions with chain A Hydrophobic interactions: A:L.27, A:L.27, A:V.35, A:V.104, A:Y.106 Hydrogen bonds: A:A.107, A:N.111 Halogen bonds: A:L.27, A:D.184

9 x SO4: SULFATE ION

SO4.4: 5 residues within 4Å: Chain A: R.113, R.170, T.200, N.202, R.204 7 PLIP interactions: 7 interactions with chain A Hydrogen bonds: A:N.202, A:N.202 Water bridges: A:T.201, A:N.202 Salt bridges: A:R.113, A:R.170, A:R.204 SO4.5: 3 residues within 4Å: Chain A: G.82, K.83, Y.156 1 PLIP interactions: 1 interactions with chain A Hydrogen bonds: A:K.83 SO4.6: 6 residues within 4Å: Chain A: W.227, Y.244, H.260, R.261, M.262, W.280 3 PLIP interactions: 3 interactions with chain A Hydrogen bonds: A:Y.244, A:R.261, A:M.262 SO4.7: 5 residues within 4Å: Chain A: K.47, P.48, N.49, R.50 Ligands: SO4.9 5 PLIP interactions: 5 interactions with chain A Hydrogen bonds: A:K.47, A:N.49, A:N.49, A:R.50 Salt bridges: A:R.50 SO4.8: 7 residues within 4Å: Chain A: Y.115, D.142, S.145, C.146, Q.149, N.178, M.180 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:D.142, A:Q.149 SO4.9: 3 residues within 4Å: Chain A: N.49, R.50 Ligands: SO4.7 1 PLIP interactions: 1 interactions with chain A Salt bridges: A:R.50 SO4.10: 6 residues within 4Å: Chain A: Q.117, R.120, R.204, G.240, G.241, S.242 4 PLIP interactions: 4 interactions with chain A Hydrogen bonds: A:Q.117, A:R.204, A:S.242 Salt bridges: A:R.120 SO4.11: 4 residues within 4Å: Chain A: A.158, T.289, F.290, K.291 3 PLIP interactions: 3 interactions with chain A Hydrogen bonds: A:T.289, A:F.290, A:K.291 SO4.12: 7 residues within 4Å: Chain A: S.140, V.144, F.237, N.267, C.268, T.269, L.272 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:N.267, A:T.269

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Hudkins, R.L. et al., Discovery of TYRA-300: First Oral Selective FGFR3 Inhibitor for the Treatment of Urothelial Cancers and Achondroplasia. J.Med.Chem. (2024)

Release Date

2024-09-25

Peptides

Fibroblast growth factor receptor 1: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Fibroblast growth factor receptor 1

Related Entries With Identical Sequence